Costs of Introducing and Delivering HPV Vaccines in Low and Lower Middle Income Countries: Inputs for GAVI Policy on Introduction Grant Support to Countries

This article, published in PLoS ONE, describes the data and analysis shared with GAVI Alliance policymakers regarding their support of human papillomavirus (HPV) vaccine. The authors review why strategies and costs for HPV vaccine delivery are different from other vaccines and what is known about the cost components. This paper demonstrates the importance of country-level cost data to inform global donor policies for vaccine introduction support. Such data are also valuable for informing national decisions on HPV vaccine introduction.

Author(s): Levin A, Wang SA, Levin C, Tsu V, Hutubessy R

Published: 2014

  • Visit web page (English)

    (Located at www.plosone.org)

    Citation: Levin A, Wang SA, Levin C, Hutubessy R. Costs of Introducing and Delivering HPV Vaccines in Low and Lower Middle Income Countries: Inputs for GAVI Policy on Introduction Grant Support to Countries. PLoS ONE. 2014;9(6):e101114.